In this edition, nearly $1 million in grants to aid diversity, equity, inclusion research; topical halcinonide may benefit patients with psoriasis; Asian patients may experience earlier mycosis fungoides diagnosis and more. Read the full coverage here: Nearly $1 million in grants to aid dermatology research in diversity, equity, inclusion Topical halcinonide may benefit patients with psoriasis with inadequate biologics response Asian patients may experience earlier mycosis fungoides diagnosis, better outcomes COVID-19 pandemic led to delayed melanoma diagnoses, more advanced tumors Dupilumab use correlates with S. aureus reductions, atopic dermatitis improvements References: Bagel J, et al. J Drugs Dermatol. 2023;doi:10.36849/JDD.6830. Chen Z, et al. JAMA Dermatol. 2023;doi:10.1001/jamadermatol.2023.2634. Press Release Simpson EL, et al. J Allergy Clin Immunol. 2023;doi:10.1016/j.jaci.2023.05.026. Xiong D, et al. J Am Acad Dermatol. 2023;doi:10.1016/j.jaad.2023.08.040.

Ver todos los episodios